JNCE Annual Accounts Payable
$2.10 M
+$421.00 K+25.15%
31 December 2022
Summary:
As of February 5, 2025, JNCE annual accounts payable is $2.10 million, with the most recent change of +$421.00 thousand (+25.15%) on December 31, 2022. During the last 3 years, it has fallen by -$365.00 thousand (-14.84%).JNCE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JNCE Quarterly Accounts Payable
$2.10 M
+$980.00 K+87.89%
31 December 2022
Summary:
As of February 5, 2025, JNCE quarterly accounts payable is $2.10 million, with the most recent change of +$980.00 thousand (+87.89%) on December 31, 2022. Over the past year, it has increased by +$421.00 thousand (+25.15%).JNCE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JNCE Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +25.1% |
| 3 y3 years | -14.8% | -14.8% |
| 5 y5 years | -26.5% | -26.5% |
JNCE Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -40.3% | -63.3% |
Jounce Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2.10 M(+25.1%) | $2.10 M(+87.9%) |
| Sept 2022 | - | $1.11 M(-67.6%) |
| June 2022 | - | $3.44 M(+80.7%) |
| Mar 2022 | - | $1.90 M(+13.7%) |
| Dec 2021 | $1.67 M(-17.8%) | $1.67 M(-4.6%) |
| Sept 2021 | - | $1.75 M(-29.2%) |
| June 2021 | - | $2.48 M(+51.8%) |
| Mar 2021 | - | $1.63 M(-19.9%) |
| Dec 2020 | $2.04 M(-17.2%) | $2.04 M(-24.8%) |
| Sept 2020 | - | $2.71 M(-10.8%) |
| June 2020 | - | $3.03 M(-18.5%) |
| Mar 2020 | - | $3.72 M(+51.3%) |
| Dec 2019 | $2.46 M | $2.46 M(-27.8%) |
| Sept 2019 | - | $3.41 M(+31.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $2.60 M(-35.6%) |
| Mar 2019 | - | $4.03 M(+23.2%) |
| Dec 2018 | $3.27 M(+14.8%) | $3.27 M(+12.4%) |
| Sept 2018 | - | $2.91 M(-2.7%) |
| June 2018 | - | $2.99 M(-46.0%) |
| Mar 2018 | - | $5.54 M(+94.4%) |
| Dec 2017 | $2.85 M(-18.9%) | $2.85 M(-34.9%) |
| Sept 2017 | - | $4.38 M(+41.1%) |
| June 2017 | - | $3.10 M(-45.6%) |
| Mar 2017 | - | $5.71 M(+62.7%) |
| Dec 2016 | $3.51 M(+34.1%) | $3.51 M(+86.1%) |
| Sept 2016 | - | $1.89 M(-27.9%) |
| Dec 2015 | $2.62 M(+247.7%) | $2.62 M |
| Dec 2014 | $753.00 K | - |
FAQ
- What is Jounce Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Jounce Therapeutics?
- What is Jounce Therapeutics annual accounts payable year-on-year change?
- What is Jounce Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly accounts payable year-on-year change?
What is Jounce Therapeutics annual accounts payable?
The current annual accounts payable of JNCE is $2.10 M
What is the all time high annual accounts payable for Jounce Therapeutics?
Jounce Therapeutics all-time high annual accounts payable is $3.51 M
What is Jounce Therapeutics annual accounts payable year-on-year change?
Over the past year, JNCE annual accounts payable has changed by +$421.00 K (+25.15%)
What is Jounce Therapeutics quarterly accounts payable?
The current quarterly accounts payable of JNCE is $2.10 M
What is the all time high quarterly accounts payable for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly accounts payable is $5.71 M
What is Jounce Therapeutics quarterly accounts payable year-on-year change?
Over the past year, JNCE quarterly accounts payable has changed by +$421.00 K (+25.15%)